New Member Pfizer Joins R Consortium

[This article was first published on R Consortium, and kindly contributed to R-bloggers]. (You can report issue about the content on this page here)
Want to share your content on R-bloggers? click here if you have a blog, or here if you don't.

SAN FRANCISCO, May 2, 2022 – The R Consortium, a Linux Foundation project supporting the R Foundation and worldwide R community, today announced that Pfizer has joined as a Silver Member.

“We have been using R for our work at Pfizer for over 10 years, but over the last few years we have seen an increased interest in using R and Shiny for internal decision making and regulatory interactions,” said Mike Smith, Statistical Group Lead and Head of the R Center of Excellence (CoE) at Pfizer. ”With the initiation of the R Center of Excellence, Pfizer is committing to engage with R users internally and externally, working to answer questions and solve problems using R and associated technologies in order to achieve breakthroughs in drug development and get medicines to patients more quickly and more efficiently. Joining the R Consortium as a Silver member formalises our commitment to the consortium’s efforts and working groups, engaging with others to help address some of the issues that are best solved through collaboration and partnership.”

“I am really excited to have Pfizer as a member of the R Consortium,” said Joseph Rickert, RStudio’s R Community Ambassador and R Consortium Board Chair. “Pfizer’s participation will increase the depth of our expertise in the pharmaceutical industry and enhance the R Consortium’s efforts to support industry-wide collaborative projects such as working towards FDA submissions done completely in R, and automating the process of generating the specialized statistical tables required for clinical trial reporting.”

The R Consortium has multiple separate Working Groups focused on pharmaceutical issues: RTRS (Tables), R Submissions (IT), Validation, and more. Participation in R Consortium Working Groups in the pharmaceutical space by Pfizer will help continue to expand their reach. The Working Groups add value to member companies by initiating and cultivating industry-wide collaborative projects. This is critical in the pharmaceutical industry, providing a framework for competitors to come together and cooperate under an open governance framework to build infrastructure at low-cost. To find out how you can join an R Consortium Working Group, see

About Pfizer: Breakthroughs That Change Patients’ Lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at In addition, to learn more, please visit us on and follow us on Twitter at @Pfizer and @Pfizer NewsLinkedInYouTube and like us on Facebook at

About The R Consortium

The R Consortium is a 501(c)6 nonprofit organization and Linux Foundation project dedicated to the support and growth of the R user community. The R Consortium provides support to the R Foundation and to the greater R Community for projects that assist R package developers, provide documentation and training, facilitate the growth of the R Community and promote the use of the R language. For more information about R Consortium, please visit:

About Linux Foundation

Founded in 2000, the Linux Foundation is supported by more than 1,000 members and is the world’s leading home for collaboration on open source software, open standards, open data, and open hardware. Linux Foundation projects like Linux, Kubernetes, Node.js and more are considered critical to the development of the world’s most important infrastructure. Its development methodology leverages established best practices and addresses the needs of contributors, users and solution providers to create sustainable models for open collaboration. For more information, please visit us at

The post New Member Pfizer Joins R Consortium appeared first on R Consortium.

To leave a comment for the author, please follow the link and comment on their blog: R Consortium. offers daily e-mail updates about R news and tutorials about learning R and many other topics. Click here if you're looking to post or find an R/data-science job.
Want to share your content on R-bloggers? click here if you have a blog, or here if you don't.

Never miss an update!
Subscribe to R-bloggers to receive
e-mails with the latest R posts.
(You will not see this message again.)

Click here to close (This popup will not appear again)